Genomic Health, Inc. (GHDX) Analysts See $0.09 EPS; Hecla Mining Company (HL) Shorts Raised By 0.64%

January 15, 2018 - By Stephen Andrade

Analysts expect Genomic Health, Inc. (NASDAQ:GHDX) to report $0.09 EPS on February, 13.They anticipate $0.05 EPS change or 125.00% from last quarter’s $0.04 EPS. GHDX’s profit would be $3.13M giving it 98.33 P/E if the $0.09 EPS is correct. After having $0.03 EPS previously, Genomic Health, Inc.’s analysts see 200.00% EPS growth. The stock decreased 1.53% or $0.55 during the last trading session, reaching $35.4. About 106,281 shares traded. Genomic Health, Inc. (NASDAQ:GHDX) has risen 23.46% since January 15, 2017 and is uptrending. It has outperformed by 6.76% the S&P500.

Hecla Mining Company (NYSE:HL) had an increase of 0.64% in short interest. HL’s SI was 10.64 million shares in January as released by FINRA. Its up 0.64% from 10.58M shares previously. With 3.70 million avg volume, 3 days are for Hecla Mining Company (NYSE:HL)’s short sellers to cover HL’s short positions. The SI to Hecla Mining Company’s float is 2.71%. The stock decreased 1.78% or $0.08 during the last trading session, reaching $4.41. About 5.52M shares traded or 18.85% up from the average. Hecla Mining Company (NYSE:HL) has risen 41.69% since January 15, 2017 and is uptrending. It has outperformed by 24.99% the S&P500.

Since October 13, 2017, it had 2 buys, and 1 sale for $229,185 activity. HALL LINDSAY A also bought $49,491 worth of Hecla Mining Company (NYSE:HL) shares. Nethercutt George R Jr also sold $327,556 worth of Hecla Mining Company (NYSE:HL) shares. BAKER PHILLIPS S JR also bought $48,880 worth of Hecla Mining Company (NYSE:HL) on Thursday, December 14.

Hecla Mining Company, together with its subsidiaries, discovers, acquires, develops, produces, and markets precious and base metal deposits worldwide. The company has market cap of $1.76 billion. The firm offers unrefined gold and silver bullion bars to precious metals traders; and lead, zinc, and bulk concentrates to custom smelters and brokers. It has a 73.5 P/E ratio. It owns 100% interests in the Greens Creek mine located on Admiralty Island in Southeast Alaska; the Lucky Friday unit located in the Coeur dÂ’Alene mining district in northern Idaho; the Casa Berardi mine located in the Abitibi region of north-western Quebec, Canada; and the San Sebastian unit located in the state of Durango, Mexico.

Investors sentiment decreased to 1.03 in Q3 2017. Its down 0.31, from 1.34 in 2017Q2. It is negative, as 23 investors sold Hecla Mining Company shares while 53 reduced holdings. 26 funds opened positions while 52 raised stakes. 222.00 million shares or 0.87% more from 220.08 million shares in 2017Q2 were reported. Eqis Cap Management holds 0.01% or 37,383 shares in its portfolio. Us National Bank De holds 0% or 1,167 shares in its portfolio. Commerce Of Vermont invested in 1,800 shares or 0% of the stock. Wells Fargo & Mn, California-based fund reported 965,203 shares. California-based Fdx has invested 0.01% in Hecla Mining Company (NYSE:HL). Dimensional Fund Advisors Lp reported 33.54 million shares or 0.07% of all its holdings. Commercial Bank Of America De invested in 0% or 580,871 shares. Balyasny Asset Mngmt has invested 0% of its portfolio in Hecla Mining Company (NYSE:HL). Strs Ohio holds 0% in Hecla Mining Company (NYSE:HL) or 2,200 shares. Public Employees Retirement Of Ohio owns 12,133 shares for 0% of their portfolio. Two Sigma Lc has invested 0.01% in Hecla Mining Company (NYSE:HL). Alliancebernstein Limited Partnership holds 492,281 shares. Plante Moran Advsr Limited Liability Company owns 6 shares. Amalgamated Natl Bank has invested 0.01% in Hecla Mining Company (NYSE:HL). Ww holds 1.67M shares.

Among 15 analysts covering Hecla Mining Company (NYSE:HL), 10 have Buy rating, 0 Sell and 5 Hold. Therefore 67% are positive. Hecla Mining Company had 51 analyst reports since August 13, 2015 according to SRatingsIntel. As per Tuesday, May 31, the company rating was maintained by RBC Capital Markets. The firm earned “Mkt Perform” rating on Wednesday, July 20 by FBR Capital. The rating was maintained by RBC Capital Markets on Wednesday, July 5 with “Hold”. RBC Capital Markets maintained it with “Sector Perform” rating and $2.75 target in Thursday, September 17 report. The rating was upgraded by Scotia Capital to “Sector Perform” on Wednesday, July 13. BMO Capital Markets maintained Hecla Mining Company (NYSE:HL) rating on Wednesday, June 28. BMO Capital Markets has “Hold” rating and $600 target. The rating was upgraded by Canaccord Genuity on Tuesday, November 14 to “Buy”. Deutsche Bank maintained Hecla Mining Company (NYSE:HL) rating on Monday, October 5. Deutsche Bank has “Buy” rating and $3.5 target. The firm has “Hold” rating by Canaccord Genuity given on Thursday, October 5. The rating was upgraded by FBR Capital on Thursday, November 30 to “Buy”.

Investors sentiment increased to 2.32 in 2017 Q3. Its up 0.66, from 1.66 in 2017Q2. It increased, as 6 investors sold Genomic Health, Inc. shares while 25 reduced holdings. 21 funds opened positions while 51 raised stakes. 30.86 million shares or 1.02% more from 30.55 million shares in 2017Q2 were reported. Bogle Invest Mgmt Ltd Partnership De has 44,405 shares for 0.1% of their portfolio. Nationwide Fund Advisors has invested 0% in Genomic Health, Inc. (NASDAQ:GHDX). Products Prtn Lc invested in 16,763 shares. State Board Of Administration Of Florida Retirement Sys stated it has 0% of its portfolio in Genomic Health, Inc. (NASDAQ:GHDX). Convergence Inv Ptnrs Lc, a Wisconsin-based fund reported 35,598 shares. Vanguard Grp Inc owns 0% invested in Genomic Health, Inc. (NASDAQ:GHDX) for 1.68M shares. Rhumbline Advisers, a Massachusetts-based fund reported 24,934 shares. Moreover, Ameritas has 0% invested in Genomic Health, Inc. (NASDAQ:GHDX). Geode Cap Management Ltd Limited Liability Company holds 211,001 shares or 0% of its portfolio. First Quadrant L P Ca, California-based fund reported 208 shares. Massachusetts-based State Street has invested 0% in Genomic Health, Inc. (NASDAQ:GHDX). 13,113 are owned by Raymond James & Associate. Balyasny Asset Mngmt Limited Co accumulated 10,000 shares. Federated Investors Pa invested in 1,349 shares. Boston Advisors Lc, Massachusetts-based fund reported 13,750 shares.

Among 11 analysts covering Genomic Health (NASDAQ:GHDX), 2 have Buy rating, 3 Sell and 6 Hold. Therefore 18% are positive. Genomic Health had 30 analyst reports since August 5, 2015 according to SRatingsIntel. As per Wednesday, January 4, the company rating was downgraded by Cowen & Co. The firm has “Hold” rating by Canaccord Genuity given on Wednesday, August 5. Jefferies maintained the shares of GHDX in report on Friday, October 20 with “Hold” rating. The rating was downgraded by JP Morgan to “Underweight” on Wednesday, December 13. On Monday, September 25 the stock rating was maintained by Canaccord Genuity with “Buy”. The stock of Genomic Health, Inc. (NASDAQ:GHDX) earned “Hold” rating by Jefferies on Wednesday, August 17. Jefferies maintained Genomic Health, Inc. (NASDAQ:GHDX) rating on Tuesday, September 12. Jefferies has “Hold” rating and $33.0 target. The firm has “Neutral” rating given on Monday, January 11 by Piper Jaffray. The rating was maintained by Canaccord Genuity with “Buy” on Monday, August 14. Cowen & Co upgraded the shares of GHDX in report on Thursday, November 19 to “Outperform” rating.